Literature DB >> 33865103

Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease.

Valeria Lucchino1, Luana Scaramuzzino2, Stefania Scalise3, Katia Grillone4, Michela Lo Conte5, Claudia Esposito6, Umberto Aguglia7, Edoardo Ferlazzo8, Nicola Perrotti9, Paola Malatesta10, Elvira Immacolata Parrotta11, Giovanni Cuda12.   

Abstract

Unverricht-Lundborg disease (ULD) is an inherited form of progressive myoclonus epilepsy caused by mutations in the gene encoding Cystatin B (CSTB), an inhibitor of lysosomal proteases. The most common mutation described in ULD patients is an unstable expansion of a dodecamer sequence located in the CSTB gene promoter. This expansion is causative of the downregulation of CSTB gene expression and, consequently, of its inhibitory activity. Here we report the generation of induced pluripotent stem cell (iPSC) lines from two Italian siblings having a family history of ULD and affected by different clinical and pathological phenotypes of the disease.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2021        PMID: 33865103     DOI: 10.1016/j.scr.2021.102329

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  2 in total

1.  The Role of NMP22 and CSTB Levels in Predicting Postoperative Recurrence of Bladder Cancer.

Authors:  Changkun Huang; Xiaolin Ai; Liping Hu; Da Ren
Journal:  J Immunol Res       Date:  2022-05-19       Impact factor: 4.493

2.  Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity.

Authors:  Stefania Scalise; Clara Zannino; Valeria Lucchino; Michela Lo Conte; Luana Scaramuzzino; Pierangelo Cifelli; Tiziano D'Andrea; Katiuscia Martinello; Sergio Fucile; Eleonora Palma; Antonio Gambardella; Gabriele Ruffolo; Giovanni Cuda; Elvira Immacolata Parrotta
Journal:  Biomedicines       Date:  2022-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.